Ecstacy (MDMA) and Parkinsons disease.

James Teo james at
Thu Feb 22 16:56:19 EST 2001

Well, all I could remember from the programme is that the people
working on it are in Manchester and in Kings College London. 
Watched the programme and realised that it wasn't as revolutionising
as the programme-makers claim since the action is believed to be in
the subthalamic nucleus. Also, I was rather surprised that they didn't
test it out on any other patients.

More information about the Neur-sci mailing list